Original Research
Published on 28 Jul 2022
Distribution and efficacy of ofatumumab and ocrelizumab in humanized CD20 mice following subcutaneous or intravenous administration
in Multiple Sclerosis and Neuroimmunology
- 16,261 views
- 33 citations
Original Research
Published on 28 Jul 2022
in Multiple Sclerosis and Neuroimmunology
Review
Published on 28 Jul 2022
in Multiple Sclerosis and Neuroimmunology
Review
Published on 28 Jul 2022
in Multiple Sclerosis and Neuroimmunology
Review
Published on 26 Jul 2022
in Multiple Sclerosis and Neuroimmunology
Systematic Review
Published on 26 Jul 2022
in Multiple Sclerosis and Neuroimmunology
Case Report
Published on 25 Jul 2022
in Multiple Sclerosis and Neuroimmunology
Review
Published on 22 Jul 2022
in Multiple Sclerosis and Neuroimmunology
Case Report
Published on 18 Jul 2022
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 15 Jul 2022
in Multiple Sclerosis and Neuroimmunology
Review
Published on 14 Jul 2022
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 14 Jul 2022
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 13 Jul 2022
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 12 Jul 2022
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 11 Jul 2022
in Multiple Sclerosis and Neuroimmunology
Review
Published on 11 Jul 2022
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 07 Jul 2022
in Multiple Sclerosis and Neuroimmunology
Case Report
Published on 06 Jul 2022
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 06 Jul 2022
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 04 Jul 2022
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 01 Jul 2022
in Multiple Sclerosis and Neuroimmunology
Review
Published on 30 Jun 2022
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 28 Jun 2022
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 27 Jun 2022
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 23 Jun 2022
in Multiple Sclerosis and Neuroimmunology